Solo
2Pages

The preferred first-line therapy for glaucoma, SLT. Designed specifically for slective laser trabeculoplasty (SLT), Solo allows you to perform quick and highly accurate glaucoma laser treatment customized to each individual patient’s response. LiGHT Trial1 confirms SLT as preferred first-line therapy for glaucoma T he pivotal results of the multi-center LiGHT trial compared the use of SLT versus drops as a first-line treatment for treatment-naive patients who had POAG or OHT over 36 months. SLT (329 patients) Eye drops (323 patients) 74.2% of SLT patients reached target IOP, drop-free. ellex.com 1 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, et al.; on behalf of the LiGHT Trial Study Group.

The industry’s most advanced SLT laser platform, from Ellex® SLT from Ellex® Treat Glaucoma - naturally Custom-designed optics that provide an enhanced view of the trabecular meshwork Stimulate the eye’s natural healing response LED illumination for superior visualization and greater patient benefits Ultra-stable laser energy output Sharp edged SLT aiming beam for critical focus Comprehensive energy tracking system, regulating settings for extended duration Eliminate the burn and scar tissue associated with ALT Eliminate the issues of compliance and side effects associated with medications...